McKinsey Settles For $45 Million After Boosting Opioid Sales In Nevada

Fight Censorship, Share This Post!

The consulting firm advised Purdue Pharma to “turbocharge” their Oxycontin sales by issuing more prescription doses, killing thousands in Nevada.


Fight Censorship, Share This Post!

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.